Skip to content

Explore Grants

Recipient Purpose Term Source Amount
Abortion Care Network To pilot and evaluate a contraception gap fund and professional development program to support women's healthcare providers. 2018 - 2020 LJAF $602,027
Albert Einstein College of Medicine To conduct a randomized control trial to examine the impact of medical cannabis on opioid analgesic use. 2018 - 2022 LJAF $2,054,259
Alliance for Health Policy To educate health policy stakeholders and the public about the ways that prescription drug pricing impacts health care costs. 2016 - 2017 LJAF $156,494
Alliance for Health Policy To host a bipartisan convening to discuss consolidation trends in health care markets. 2018 LJAF $27,456
Alliance for Health Policy To convene health policy experts, key stakeholders, and policymakers to discuss policy solutions to address rising health care costs. 2018 - 2020 LJAF $213,780
Association for Community Affiliated Plans To analyze the ways that dual eligible special needs plans are utilizing non-medical supplemental benefits. 2019 - 2020 LJAF $242,281
Behavioral Ideas Lab, Inc. To design, implement, and test a set of behavioral interventions in emergency departments to improve outcomes for patients with opioid use disorder. 2018 - 2019 LJAF $489,230
Bioethics International, Inc. To help expand the Good Pharma Scorecard. 2015 - 2021 LJAF $4,555,858
Bipartisan Policy Center Inc. To develop practical solutions for improving quality and controlling costs in the nation's health care system. 2014 - 2015 LJAF $1,244,200
Bipartisan Policy Center Inc. To conduct a comprehensive review of how federal and state funding is being allocated to address the opioid epidemic. 2018 - 2019 LJAF $255,042
Bipartisan Policy Center Inc. To analyze policy options related to reference pricing and patent and market exclusivity. 2019 - 2020 LJAF $197,208
Bipartisan Policy Center Inc. To produce near-term policy recommendations for increasing integration between Medicare and Medicaid. 2019 - 2020 LJAF $308,960
Board of Regents Nevada System of Higher Education To evaluate the feasibility and effectiveness of the Mobile Recovery Outreach Team intervention in improving outcomes for opioid overdose survivors treated in emergency rooms in Nevada. 2018 - 2019 LJAF $217,445
Board of Regents Nevada System of Higher Education To evaluate the feasibility and effectiveness of the Mobile Recovery Outreach Team intervention on opioid overdose survivors treated in Nevada's emergency rooms. 2019 - 2022 LJAF $1,442,934
Brigham & Women's Hospital Inc. To support the Program On Regulation, Therapeutics, And Law. 2017 - 2020 LJAF $3,268,850
Brigham & Women's Hospital Inc. To evaluate the impact of Pharmacy Benefits Managers on prescription drug pricing. 2017 - 2018 LJAF $77,315
Brigham & Women's Hospital Inc. To support the Promoting a Competitive Market for High-Cost Biologic Drugs project. 2019 - 2021 LJAF $470,386
Brigham & Women's Hospital Inc. To support the Program On Regulation, Therapeutics, and Law, which will evaluate the impact of drug innovation incentive policies. 2016 - 2017 LJAF $742,905
Brigham & Women's Hospital Inc. To support the Program On Regulation, Therapeutics, And Law Biomarker Research Consortium. 2016 - 2020 LJAF $2,024,093
Brookings institution To evaluate the prevalence, drivers, and policy implications of surprise medical billing. 2018 - 2020 LJAF $1,321,496
Brookings institution To host a convening of diverse experts to discuss alternative mechanisms to fund prescription drug innovation in the pharmaceutical community. 2019 LJAF $27,011
Catalyst for Payment Reform, Inc To design and pilot a scorecard that will assess alternative health care payment reform models. 2016 - 2019 LJAF $438,276
Center for American Progress To provide general operating support. 2019 - 2021 LJAF $237,864
Center for Health Policy Development To support a working group of state health policy experts and stakeholders to examine emerging strategies for addressing the high cost of prescription drugs. 2016 - 2017 LJAF $146,271
Arnold A decorative icon